HUTCHMED (China) (HCM) Income from Continuing Operations (2015 - 2021)

HUTCHMED (China)'s (HCM) quarterly Income from Continuing Operations came in at 264251000.0 in Q4 2021, down 128.72% on a QoQ basis from 115534000.0 in Q2 2021.

HUTCHMED (China) (HCM) Income from Continuing Operations (2015 - 2021) Analysis & Trends

HUTCHMED (China) (HCM) has 6 years of Income from Continuing Operations data on file, last reported at 264251000.0 in Q4 2021.

  • On a quarterly basis, Income from Continuing Operations changed N/A year-over-year to 264251000.0 in Q4 2021; TTM through Dec 2021 was 424974000.0, a N/A change from a year earlier, with the FY2025 full-year figure at 64438434.71, up 836.98% from the prior year.
  • Income from Continuing Operations for Q4 2021 stood at 264251000.0, down from 115534000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for HCM reached as high as 70120000.0 in Q2 2018 and fell as low as 264251000.0 in Q4 2021.
  • Historically, Income from Continuing Operations has averaged 31537230.77 across 4 years, with a median of 22305000.0 in 2018.
  • Across the five-year window, Income from Continuing Operations surged 250.63% in 2019 and plunged 832.2% in 2021, its largest moves.
  • Year by year, Income from Continuing Operations stood at 22093000.0 in 2018, then soared by 183.6% to 62655000.0 in 2019, then tumbled by 74.82% to 15779000.0 in 2020, then sank by 1774.7% to 264251000.0 in 2021.
  • Per Business Quant data, the three most recent Income from Continuing Operations figures were 264251000.0 in Q4 2021, 115534000.0 in Q2 2021, and 60968000.0 in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 370.00 Mn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 601.00 Mn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn -3.58 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 274.90 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 176.40 Mn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 197.90 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 57.00 Mn
10 HUTCHMED (China) 9.45 Bn 9.45 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2021 -264.25 Mn
Jun 30, 2021 -115.53 Mn
Mar 31, 2021 -60.97 Mn
Jun 30, 2020 15.78 Mn
Mar 31, 2020 -30.28 Mn
Dec 31, 2019 62.66 Mn
Sep 30, 2019 -34.24 Mn
Jun 30, 2019 -99.44 Mn
Mar 31, 2019 33.60 Mn
Dec 31, 2018 22.09 Mn
Sep 30, 2018 12.78 Mn
Jun 30, 2018 70.12 Mn
Mar 31, 2018 -22.31 Mn
Jun 30, 2016 29.56 Mn
Jun 30, 2015 23.49 Mn